SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
The Tri-City Healthcare District Board of Directors has approved the purchase and installation of the most advanced computed tomography (CT) scanner on the market, enabling its radiologists to make quick and accurate diagnoses for patients.
Aethlon Medical Inc. announced Monday that it has withdrawn its registration statement on Form S-1 originally filed April 17 with the Securities and Exchange Commission.
ATyr Pharma Inc. is planning to raise approximately $76 million in an IPO May 7th.
AmpliPhi BioSciences Corp., which develops antibacterial therapies to treat drug resistant infections, has named M. Scott Salka as the new chief executive officer.
Pharmaceutical companies in California will dodge additional red tape this year as the vote on a controversial health care bill was delayed yet again.
MEDICINE: Opens Door for Research, Business Prospects
The University of San Diego is building a research facility on campus that will not only benefit faculty and students, but serve as a resource for local health care companies.
BIOTECH: Drug Cos., Other Firms Find Ways To Face Water Shortage
It takes a lot of water to make a drug.
Isis Pharmaceuticals Inc. announced that it has earned a $10 million milestone payment from Biogen Inc. associated with the validation of an undisclosed target to treat a neurological disorder.
Viking Therapeutics Inc. priced its revised initial public offering Wednesday, offering 3 million shares of common stock at $8 per share to raise $24 million.
Dexcom Inc., a company that makes continuous glucose monitoring devices for patients with diabetes, reported a net loss of $12.9 million on revenue of $72.8 million for the first quarter of 2015 – a 55 percent growth in revenue year-over-year.
Scripps Health’s Medical Response Team will be deploying to Nepal to aid in earthquake relief efforts under the auspices of the International Medical Corps (IMC).
Huya Bioscience International LLC has raised $48 million in debt financing, according to a recent filing with the Securities and Exchange Commission.
Edico Genome Inc. announced Monday a faster analysis of a whole genome sequence.
La Jolla Pharmaceutical Co., a business developing therapies for life-threatening diseases, announced that Dr. Lakhmir Chawla will be joining the company as chief medical officer, effective July 1.
Quidel Corp. reported strong financial results for the first quarter of 2015 with revenue up 31 percent, according to a recent earnings statement.